| Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia RG Owen, SP Treon, A Al-Katib, R Fonseca, PR Greipp, ML McMaster, ... Seminars in oncology 30 (2), 110-115, 2003 | 1107 | 2003 |
| Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia. A Osterborg, MJ Dyer, D Bunjes, GA Pangalis, Y Bastion, D Catovsky, ... Journal of Clinical Oncology 15 (4), 1567-1574, 1997 | 666 | 1997 |
| Malignant lymphoma arising in angio‐immunoblastic lymphadenopathy BN Nathwani, H Rappaport, EM Moran, GA Pangalis, H Kim Cancer 41 (2), 578-606, 1978 | 339 | 1978 |
| Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients PL Zinzani, M Martelli, M Bertini, AM Gianni, L Devizzi, M Federico, ... haematologica 87 (12), 1258-1264, 2002 | 243 | 2002 |
| Clinical approach to lymphadnopathy GA Pangalis Semin Oncol 20, 570-582, 1993 | 226* | 1993 |
| Malignant lymphoma, well differentiated lymphocytic. Its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenström GA Pangalis, BN Nathwani, H Rappaport Cancer 39 (3), 999-1010, 1977 | 223 | 1977 |
| Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma MC Kyrtsonis, TP Vassilakopoulos, N Kafasi, S Sachanas, T Tzenou, ... British journal of haematology 137 (3), 240-243, 2007 | 204 | 2007 |
| Senescence and senotherapeutics: A new field in cancer therapy V Myrianthopoulos, K Evangelou, PVS Vasileiou, T Cooks, ... Pharmacology & therapeutics 193, 31-49, 2019 | 175 | 2019 |
| Demonstration of cell surface antigens and their antibodies by the peroxidase-antiperoxidase method. KJ Bross, GA Pangalis, CG Staatz, KG Blume Transplantation 25 (6), 331-334, 1978 | 173 | 1978 |
| Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing M Parry, MJJ Rose-Zerilli, V Ljungström, J Gibson, J Wang, R Walewska, ... Clinical Cancer Research 21 (18), 4174-4183, 2015 | 167 | 2015 |
| Acute (“malignant”) myelosclerosis RM Bearman, GA Pangalis, H Rappaport Cancer 43 (1), 279-293, 1979 | 164 | 1979 |
| CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin’s disease: associations with presenting features and clinical outcome GZ Rassidakis, LJ Medeiros, S Viviani, V Bonfante, GP Nadali, ... Journal of Clinical Oncology 20 (5), 1278-1287, 2002 | 147 | 2002 |
| BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens GZ Rassidakis, LJ Medeiros, TP Vassilakopoulos, S Viviani, V Bonfante, ... Blood 100 (12), 3935-3941, 2002 | 139 | 2002 |
| B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic … GA Pangalis, MK Angelopoulou, TP Vassilakopoulos, MP Siakantaris, ... Seminars in hematology 36 (2), 104-114, 1999 | 139 | 1999 |
| Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care TP Vassilakopoulos, GA Pangalis, A Katsigiannis, SG Papageorgiou, ... The oncologist 17 (2), 239-249, 2012 | 137 | 2012 |
| A novel immunological assay for hepcidin quantification in human serum V Koliaraki, M Marinou, TP Vassilakopoulos, E Vavourakis, E Tsochatzis, ... PloS one 4 (2), e4581, 2009 | 120 | 2009 |
| Rituximab monotherapy is highly effective in splenic marginal zone lymphoma C Kalpadakis, GA Pangalis, MN Dimopoulou, TP Vassilakopoulos, ... Hematological oncology 25 (3), 127-131, 2007 | 119 | 2007 |
| Angioimmunoblastic lymphadenopathy long‐term follow‐up study GA Pangalis, EM Moran, BN Nathwani, RJ Zelman, H Kim, H Rappaport Cancer 52 (2), 318-321, 1983 | 102 | 1983 |
| Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy C Kalpadakis, GA Pangalis, MK Angelopoulou, S Sachanas, ... The oncologist 18 (2), 190-197, 2013 | 101 | 2013 |
| Blood and bone marrow findings in angioimmunoblastic lymphadenopathy GA Pangalis, EM Moran, H Rappaport Blood 51 (1), 71-83, 1978 | 101 | 1978 |
